Stay updated on Branaplam Safety in Early Huntington's Disease Clinical Trial
Sign up to get notified when there's something new on the Branaplam Safety in Early Huntington's Disease Clinical Trial page.

Latest updates to the Branaplam Safety in Early Huntington's Disease Clinical Trial page
- ChecktodayChange DetectedThe footer's displayed site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA site-wide NIH notice about terminology changes appears above the page, and the site revision advances from v3.7.1 to v3.7.2; the study page continues to display a 403 error.SummaryDifference1%

- Check28 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1. The study page still displays a 403 error.SummaryDifference0.2%

- Check42 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previous content and preventing access to the study record and navigation. This indicates restricted access to the trial information.SummaryDifference21%

- Check49 days agoChange DetectedVersion metadata updated from v3.6.6 to v3.7.0, indicating a platform or content management update. No study details or visible page content appear to be altered as part of this change.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page now displays Revision: v3.6.6, indicating an updated page version has been deployed rather than changes to the study information.SummaryDifference0.0%

Stay in the know with updates to Branaplam Safety in Early Huntington's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Branaplam Safety in Early Huntington's Disease Clinical Trial page.